Stocktoria

Allarity Therapeutics, Inc. ALLR

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-12-21

Allarity Therapeutics, Inc. statistics & valuation

Market cap$20.7M
P / S64.6×
P / B2.1×
Net margin-3509.7%
Return on equity-114.3%
FCF margin-4633.8%
Return on capital-128.3%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-3509.70% 202020212022202320242025
Gross margin (%)
202020212022202320242025
Operating margin (%)
-3939.10% 202020212022202320242025
Return on equity (%)
-24.60% -146.80% -207.60% -114.30% 202020212022202320242025
Shares outstanding
4.3M 8.1M 11356 2.0M 7.3M 16.1M 202020212022202320242025
Net debt ($)
$615000 $2.5M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-19.80% -53.70% -110.40% -100.30% -108.20% -61.50% 202020212022202320242025
Free cash flow margin (%)
-4633.80% 202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
-$4.19 -$3093.42 -$10.26 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-3939.1%—————
Net margin-3509.7%—————
FCF margin-4633.8%—————
Return on assets-61.5%-108.2%-100.3%-110.4%-53.7%-19.8%
Return on equity-114.3%-207.6%432.6%14210.6%-146.8%-24.6%
Debt / equity——-0.98×-23.40×——
Current ratio2.132.060.140.441.030.31

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.